FOGNANI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 3.386
EU - Europa 2.212
AS - Asia 1.157
SA - Sud America 168
AF - Africa 29
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.974
Nazione #
US - Stati Uniti d'America 3.347
PL - Polonia 728
RU - Federazione Russa 689
SG - Singapore 330
CN - Cina 248
HK - Hong Kong 189
IT - Italia 171
IE - Irlanda 167
VN - Vietnam 163
BR - Brasile 133
SE - Svezia 131
FI - Finlandia 80
KR - Corea 79
DE - Germania 74
FR - Francia 53
GB - Regno Unito 39
IN - India 37
JP - Giappone 25
CA - Canada 23
AU - Australia 21
ES - Italia 21
ID - Indonesia 20
AR - Argentina 16
JO - Giordania 15
TR - Turchia 14
BE - Belgio 13
MX - Messico 11
ZA - Sudafrica 10
IQ - Iraq 9
NL - Olanda 9
CI - Costa d'Avorio 7
UA - Ucraina 7
EC - Ecuador 6
PH - Filippine 6
BD - Bangladesh 4
CO - Colombia 4
MA - Marocco 4
RO - Romania 4
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
NG - Nigeria 3
UZ - Uzbekistan 3
VE - Venezuela 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
LT - Lituania 2
MD - Moldavia 2
MT - Malta 2
NP - Nepal 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
Totale 6.974
Città #
Santa Clara 804
Warsaw 725
Ashburn 375
Fairfield 279
Singapore 214
Dublin 167
Hong Kong 154
San Jose 146
Woodbridge 144
Chandler 143
Cambridge 123
Seattle 121
Houston 114
Beijing 109
Wilmington 109
Ann Arbor 81
Seoul 76
The Dalles 67
Altamura 56
Florence 54
Lawrence 49
Ho Chi Minh City 48
Buffalo 47
Princeton 46
Lauterbourg 38
Helsinki 36
Bremen 33
Hanoi 32
Mumbai 29
Council Bluffs 28
Los Angeles 26
Munich 25
Boston 24
Medford 23
New York 23
Tokyo 22
Shanghai 21
Dong Ket 20
Falls Church 20
Boardman 19
Melbourne 19
Jakarta 14
San Diego 14
Brussels 13
Dallas 13
Barcelona 11
Clifton 11
London 11
São Paulo 11
Norwalk 10
Izmir 9
Montreal 9
Moscow 9
Turku 9
Cagliari 8
Abidjan 7
Frankfurt am Main 7
Jacksonville 7
Old Bridge 7
Phoenix 7
Atlanta 6
Johannesburg 6
Redondo Beach 6
Vancouver 5
Avigliano 4
Brooklyn 4
Chicago 4
Cluj-Napoca 4
Curitiba 4
Da Nang 4
Istanbul 4
Madrid 4
Mexico City 4
Paris 4
Washington 4
Abuja 3
Andover 3
Biên Hòa 3
Brasília 3
Chennai 3
Ferriere 3
Fortaleza 3
Guangzhou 3
Guayaquil 3
Haiphong 3
Manaus 3
Orem 3
Pistoia 3
Salt Lake City 3
Tashkent 3
Thái Bình 3
Toronto 3
Uberlândia 3
Aachen 2
An Giang Province 2
Asunción 2
Baghdad 2
Bangkok 2
Bastia umbra 2
Bern 2
Totale 5.011
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 323
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 315
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. 262
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 255
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 253
Determinanti virali e dell’ospite nella patogenesi dei disordini linfoproliferativi HCV-correlati 251
A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens 245
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 226
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 225
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 222
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 222
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 219
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 217
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 203
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
IgG3 subclass: A possible trigger of mixed cryoglobulin cascade in hepatitis C virus chronic infection 195
Host genetic determinants in HCV-related mixed cryoglobulinemia 190
MicroRNA expression in hepatitis C virus-related malignancies: A brief review 188
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 170
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? 168
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 167
Host genetic determinants in HCV-related mixed cryoglobulinemia 161
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 160
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 153
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 147
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 146
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 141
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 135
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 133
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 132
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. 131
HCV AND lymphoma: Genetic and epigenetic factors 127
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 125
Sofosbuvir/Ribavirin in GT2 HCV-Related symptomatic mixed cryoglobulinemia: an interim analysis on safety, efficacy and impact on quality of life 124
Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26 120
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 119
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 114
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 111
Totale 6.993
Categoria #
all - tutte 17.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 26 28
2021/2022316 4 26 21 16 17 23 7 22 17 17 50 96
2022/2023768 69 120 43 65 60 137 98 47 86 2 26 15
2023/2024214 10 36 41 9 9 30 3 54 4 4 5 9
2024/20251.991 85 187 124 279 641 311 14 112 91 38 63 46
2025/20261.714 238 233 96 171 197 93 222 92 212 132 28 0
Totale 6.993